SCHEMBL24401645

SCHEMBL24401645

Cc1ccc(N)c(Nc2cc(Nc3nc(C)ccc3N)cc(C(F)(F)F)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAPGEF4 Q8WZA2 2/20 0.41
▸ EGFR P00533 3/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ KDR P35968 1/20 0.39
▸ SYK P43405 1/20 0.38
▸ MAPT P10636 3/20 0.38
▸ TP53 P04637 1/20 0.38
▸ GRM4 Q14833 1/20 0.37
▸ IDH2 P48735 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ KRAS P01116 1/20 0.37
▸ SOS1 Q07889 1/20 0.37
▸ THRB P10828 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ BRAF P15056 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531552 1.00 RAPGEF4 (0.41) RAPGEF4EGFRPDGFRBKDRSYK
SCHEMBL24401644 0.77 KCNH3 (0.39) RAPGEF4EGFRPDGFRBKDRMAPT
SCHEMBL29531859 0.77 KCNH3 (0.39) RAPGEF4EGFRPDGFRBKDRMAPT
SCHEMBL29531896 0.76 FGFR4 (0.48) ALDH1A1GAA
SCHEMBL24401494 0.74 GRM4 (0.53) EGFRMAPTGRM4ALDH1A1GAA
SCHEMBL29532275 0.74 GRM4 (0.53) EGFRMAPTGRM4ALDH1A1GAA
SCHEMBL12727110 0.74 RAB9A (0.47) EGFRMAPTTP53ALDH1A1GAA
SCHEMBL13506395 0.74 CYP1A2 (0.49) EGFRMAPTALDH1A1GAARAB9A
SCHEMBL16900175 0.72 EGFR (0.49) EGFRMAPTTP53SMN1; SMN2HTT
SCHEMBL24401581 0.69 KDM4E (0.35) MAPTTP53ALDH1A1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220140258-A1 IRIDIUM COMPLEX, NITROGEN-CONTAINING TRIDENTATE CARBENE CHELATE, AND ORGANIC LIGHT-EMITTING DIODE NATIONAL TSING HUA UNIVERSITY (TW) 2022-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220140258-A1 IRIDIUM COMPLEX, NITROGEN-CONTAINING TRIDENTATE CARBENE CHELATE, AND ORGANIC LIGHT-EMITTING DIODE NR2E3, CHRM1, CBR3 RAPGEF4 2194/4885EGFR 695/4885PDGFRB 3879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback